BOSUTRIS 400MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV)

MRP: ₹5093.68

MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV): Bosutris 400MG Tablet, 30 tablets, salt bosutinib 400mg. NPPA has revised its MRP from Rs 8,343 to Rs 5,093.68 (39% lower) with effect from 09-11-2026; trade rate Rs 3,880.90. Group: BCR-ABL tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Sun Pharma. Handling/counselling: taken with food; diarrhoea is common in the first weeks. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.